FWBI - First Wave BioPharma to Present at the DealFlow MicroCap Conference | Benzinga
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it will present at the DealFlow MicroCap Conference, which will be held January 30 – February 1, 2024 at the Caesars Atlantic City Hotel & Casino, in Atlantic City, New Jersey.
Details of the event are as follows:
| Event: |
| DealFlow MicroCap Conference |
| Date: |
| January 30 – February 1, 2024 |
| Presentations: |
| Wed, Jan 31 at 10:50-11:10 AM in Track 1 (Third Floor) Thu, Feb 1 at 4:00-4:20 PM in Track 1 (Third Floor) |
| Location: |